NSTG [NASD]
NanoString Technologies, Inc.
Index- P/E- EPS (ttm)-2.78 Insider Own0.70% Shs Outstand46.00M Perf Week1.26%
Market Cap594.44M Forward P/E- EPS next Y-2.02 Insider Trans-13.26% Shs Float45.32M Perf Month-31.03%
Income-127.00M PEG- EPS next Q-0.68 Inst Own- Short Float7.99% Perf Quarter-58.09%
Sales144.50M P/S4.11 EPS this Y9.70% Inst Trans-1.03% Short Ratio4.30 Perf Half Y-69.02%
Book/sh3.16 P/B4.83 EPS next Y1.20% ROA-26.30% Target Price34.40 Perf Year-69.00%
Cash/sh8.01 P/C1.90 EPS next 5Y- ROE-68.60% 52W Range13.52 - 70.40 Perf YTD-63.89%
Dividend- P/FCF- EPS past 5Y-1.70% ROI-27.00% 52W High-78.34% Beta2.04
Dividend %- Quick Ratio7.10 Sales past 5Y10.90% Gross Margin53.30% 52W Low12.80% ATR2.01
Employees766 Current Ratio7.80 Sales Q/Q-1.60% Oper. Margin-82.80% RSI (14)31.99 Volatility14.57% 9.23%
OptionableYes Debt/Eq1.55 EPS Q/Q-38.40% Profit Margin-87.90% Rel Volume1.22 Prev Close16.73
ShortableYes LT Debt/Eq1.55 EarningsMay 10 AMC Payout- Avg Volume841.92K Price15.25
Recom1.80 SMA20-17.59% SMA50-43.37% SMA200-62.31% Volume1,002,597 Change-8.85%
Mar-24-22Initiated Canaccord Genuity Buy $50
Jan-06-21Upgrade Cowen Market Perform → Outperform $75
Sep-09-20Initiated Morgan Stanley Equal-Weight $43
Nov-15-19Initiated Stifel Buy
Oct-09-18Initiated UBS Buy
Oct-12-17Downgrade Janney Buy → Neutral
Apr-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-11-13Upgrade Robert W. Baird Neutral → Outperform $12 → $18
May-12-22 06:07AM  
May-10-22 04:01PM  
Apr-27-22 04:01PM  
Apr-18-22 04:00PM  
Apr-13-22 11:00AM  
Apr-12-22 04:35PM  
04:01PM  
Apr-08-22 03:15PM  
Apr-07-22 06:00AM  
Apr-06-22 09:55AM  
Mar-21-22 10:00AM  
Mar-04-22 10:00AM  
Mar-01-22 04:00PM  
Feb-28-22 11:15AM  
Feb-24-22 04:01PM  
06:00AM  
Feb-23-22 06:00AM  
Feb-09-22 06:00AM  
Feb-08-22 01:38PM  
Feb-07-22 06:00AM  
Jan-19-22 09:38AM  
Jan-10-22 04:01PM  
Jan-09-22 11:35AM  
11:30AM  
Dec-21-21 04:01PM  
Dec-11-21 09:29PM  
Nov-29-21 05:57AM  
Nov-11-21 06:00AM  
Nov-10-21 07:05AM  
06:00AM  
12:31AM  
Nov-09-21 05:55PM  
04:01PM  
03:54PM  
Nov-03-21 06:00AM  
Nov-02-21 03:02PM  
Oct-26-21 12:15PM  
Oct-18-21 12:26PM  
06:00AM  
Oct-12-21 06:00AM  
Oct-06-21 06:13AM  
06:00AM  
Sep-09-21 04:00PM  
Sep-01-21 04:00PM  
Aug-31-21 09:02AM  
06:00AM  
Aug-04-21 05:45PM  
04:01PM  
Jul-28-21 03:03PM  
Jul-13-21 01:16PM  
Jul-08-21 06:00AM  
Jun-22-21 06:00AM  
Jun-15-21 06:00AM  
Jun-02-21 05:39AM  
May-27-21 06:00AM  
May-20-21 06:00AM  
May-17-21 06:00AM  
May-10-21 05:15PM  
04:00PM  
May-04-21 03:00AM  
Apr-20-21 09:22AM  
Apr-08-21 06:00AM  
Apr-06-21 06:00AM  
Mar-31-21 06:00AM  
Mar-22-21 10:13AM  
Mar-09-21 06:00AM  
Mar-04-21 02:16AM  
Mar-01-21 05:25PM  
04:56PM  
04:01PM  
10:06AM  
Feb-24-21 06:00AM  
Feb-22-21 06:00AM  
Feb-17-21 06:00AM  
Feb-11-21 06:00AM  
Feb-09-21 06:00AM  
Jan-10-21 03:00PM  
Jan-06-21 12:14PM  
Jan-04-21 04:01PM  
Dec-18-20 08:51AM  
Dec-09-20 06:00AM  
Dec-01-20 06:00AM  
Nov-18-20 04:01PM  
Nov-17-20 06:00AM  
Nov-12-20 04:01PM  
06:47AM  
Nov-11-20 06:00AM  
Nov-09-20 05:25PM  
05:21PM  
04:01PM  
06:00AM  
Nov-06-20 04:01PM  
Nov-02-20 12:31PM  
Oct-13-20 04:01PM  
Oct-08-20 09:33AM  
Oct-07-20 07:58PM  
Oct-06-20 04:18PM  
04:06PM  
Oct-05-20 06:00AM  
Sep-14-20 06:00AM  
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq technologies. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 15Sale27.812,43667,74085,372Mar 16 04:40 PM
Bailey K ThomasChief Financial OfficerMar 15Sale27.812,11058,67519,372Mar 16 04:40 PM
GRAY R BRADLEYPresident and CEOMar 15Sale27.818,625239,844202,298Mar 16 04:41 PM
GRAY R BRADLEYPresident and CEOMar 14Option Exercise0.0021,9940210,923Mar 16 04:41 PM
Bailey K ThomasChief Financial OfficerMar 14Option Exercise0.005,377021,482Mar 16 04:40 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 14Option Exercise0.005,377087,808Mar 16 04:40 PM
Bailey K ThomasChief Financial OfficerMar 10Sale33.815,000169,05016,105Mar 11 08:04 PM
GEORGE JANETDirectorMar 08Option Exercise0.001,67601,676Mar 09 05:26 PM
ROLLISON DANA E.DirectorMar 08Option Exercise0.001,67601,676Mar 09 05:26 PM
Bailey K ThomasChief Financial OfficerMar 08Sale33.063,058101,11021,105Mar 09 05:24 PM
GRAY R BRADLEYPresident and CEOMar 08Sale33.069,667319,630188,929Mar 09 05:25 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 08Sale33.062,96898,13482,431Mar 09 05:25 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 07Option Exercise0.006,505085,399Mar 09 05:25 PM
GRAY R BRADLEYPresident and CEOMar 07Option Exercise0.0024,5260198,596Mar 09 05:25 PM
Bailey K ThomasChief Financial OfficerMar 07Option Exercise0.007,753024,163Mar 09 05:24 PM
Bailey K ThomasChief Financial OfficerJan 27Option Exercise0.0013,709019,928Jan 31 09:48 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentJan 27Option Exercise0.0013,709085,218Jan 31 09:48 PM
GRAY R BRADLEYPresident and CEOJan 27Option Exercise0.0056,0850195,866Jan 31 09:49 PM
Bailey K ThomasChief Financial OfficerNov 17Option Exercise11.857,84392,9327,843Nov 19 04:11 PM
Bailey K ThomasChief Financial OfficerNov 17Sale46.747,843366,5800Nov 19 04:11 PM
GRAY R BRADLEYPresident and CEONov 10Option Exercise6.7212,50084,000148,324Nov 12 04:27 PM
GRAY R BRADLEYPresident and CEONov 10Sale46.2925,0001,157,299123,324Nov 12 04:27 PM
Malloy KirkDirectorSep 13Option Exercise19.333,00057,9909,510Sep 15 04:35 PM
Malloy KirkDirectorSep 13Sale59.373,000178,1106,510Sep 15 04:35 PM
GRAY R BRADLEYPresident and CEOSep 08Option Exercise6.7212,50084,000169,158Sep 10 04:38 PM
GRAY R BRADLEYPresident and CEOSep 08Sale57.9233,3341,930,804135,824Sep 10 04:38 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentSep 02Sale61.1423,1141,413,20668,270Sep 03 05:13 PM
Bailey K ThomasChief Financial OfficerAug 17Option Exercise11.857,84592,9637,845Aug 19 04:18 PM
Bailey K ThomasChief Financial OfficerAug 17Sale51.987,845407,7760Aug 19 04:18 PM
Malloy KirkDirectorAug 16Option Exercise26.451,50039,6758,010Aug 18 05:09 PM
Malloy KirkDirectorAug 16Sale55.821,50083,7306,510Aug 18 05:09 PM
BROWN J. CHADSVP, Sales & MarketingJul 30Option Exercise17.8211,106197,92011,106Aug 03 04:49 PM
BROWN J. CHADSVP, Sales & MarketingJul 30Sale62.0911,106689,5980Aug 03 04:49 PM
Malloy KirkDirectorJul 13Option Exercise23.341,50035,0108,010Jul 15 04:38 PM
Malloy KirkDirectorJul 13Sale61.161,50091,7406,510Jul 15 04:38 PM
FINNEY ELISHA WDirectorJun 16Sale58.702,760162,0124,650Jun 17 07:04 PM
Malloy KirkDirectorJun 14Option Exercise7.471681,2551,158Jun 15 04:34 PM
Malloy KirkDirectorJun 14Sale60.0516810,088990Jun 15 04:34 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentJun 11Option Exercise6.74142,967963,592223,002Jun 15 04:35 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentJun 11Sale58.94131,8277,770,33991,175Jun 15 04:35 PM
Bailey K ThomasChief Financial OfficerMay 18Option Exercise11.855,22961,9625,229May 20 04:24 PM
Bailey K ThomasChief Financial OfficerMay 18Sale51.105,229267,2170May 20 04:24 PM